Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ceribell Inc 360 N. PASTORIA AVENUE SUNNYVALE CA 94085 USA

https://ceribell.com Employees: 281 P: 800-436-0826

Sector:

Medical

Description:

CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif.

Key Statistics

Overview:

Market Capitalization, $K 813,886
Enterprise Value, $K 639,076
Shares Outstanding, K 37,096
Float, K 29,640
% Float 79.90%
Short Interest, K 1,551
Short Float 4.18%
Days to Cover 3.52
Short Volume Ratio 0.40
% of Insider Shareholders 20.10%

Financials:

Annual Sales, $ 65,440 K
Annual Net Income, $ -40,460 K
Last Quarter Sales, $ 22,590 K
Last Quarter Net Income, $ -13,470 K
EBIT, $ -56,690 K
EBITDA, $ -55,170 K

Growth:

1-Year Return 2.33%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/04/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -1.51
EPS Growth vs. Prev Qtr 2.63%
EPS Growth vs. Prev Year 80.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CBLL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.63%
Return-on-Assets % -24.80%
Profit Margin % -61.83%
Debt/Equity 0.12
Price/Sales 9.82
Price/Cash Flow N/A
Price/Book 4.90
Book Value/Share 4.48
Interest Coverage -19.33
60-Month Beta 1.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar